Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung Injury

Cited by (1,000)

Items 201–300 of 1,000

1. Potential Cytoprotective Activity of Ozone Therapy in SARS-CoV-2/COVID-19
   Gregorio Martı́nez-Sánchez, Adriana Schwartz, Vincenzo Di Donna · 2020 · Antioxidants
2. HSV Infection Induces Production of ROS, which Potentiate Signaling from Pattern Recognition Receptors: Role for S-glutathionylation of TRAF3 and 6
   Regina Gonzalez‐Dosal, Kristy Horan, Stine H. Rahbek, Hidenori Ichijo, Zhijian J. Chen, John J. Mieyal, Rune Hartmann, Søren R. Paludan · 2011 · PLoS Pathogens
3. Emerging roles for cholesterol and lipoproteins in lung disease
   Kymberly M. Gowdy, Michael B. Fessler · 2012 · Pulmonary Pharmacology & Therapeutics
4. Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation
   Reinhard Schwartz‐Albiez, Renato C. Monteiro, Moses Rodriguez, Christoph J. Binder, Yehuda Shoenfeld · 2009 · Clinical & Experimental Immunology
5. Resolution of acute lung injury and inflammation: a translational mouse model
   Brijesh V. Patel, Michael R. Wilson, Masao Takata · 2011 · European Respiratory Journal
6. β2-Adrenergic agonists augment air pollution–induced IL-6 release and thrombosis
   Sergio E. Chiarella, Saul Soberanes, Daniela Urich, Luisa Morales‐Nebreda, Recep Niğdelioğlu, David Green, James B. Young, Angel Gonzalez, Carmen M. Rosario, Alexander V. Misharin et al. · 2014 · Journal of Clinical Investigation
7. Viral Inhibitory Peptide of TLR4, a Peptide Derived from Vaccinia Protein A46, Specifically Inhibits TLR4 by Directly Targeting MyD88 Adaptor-Like and TRIF-Related Adaptor Molecule
   Tatyana Lysakova-Devine, Brian Keogh, Barry Harrington, Kamalpreet Nagpal, Annett Halle, Douglas Taylor Golenbock, Tom P. Monie, Andrew Bowie · 2010 · The Journal of Immunology
8. Oxidative Stability of Marine Phospholipids in the Liposomal Form and Their Applications
   Fei Lu, Nina Skall Nielsen, Maike Timm‐Heinrich, Charlotte Jacobsen · 2010 · Lipids
9. Inhalation of MSC-EVs is a noninvasive strategy for ameliorating acute lung injury
   Ruijing Zhao, Lina Wang, Tian Wang, Panpan Xian, Wang Hongkang, Qianfa Long · 2022 · Journal of Controlled Release
10. Excessive neutrophil levels in the lung underlie the age-associated increase in influenza mortality
    Upasana Kulkarni, Rachel L. Zemans, Candice A. Smith, Sherri Chan Wood, Jane C. Deng, Daniel R. Goldstein · 2019 · Mucosal Immunology
11. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents
    Sumanth Khadke, Nayla Ahmed, Nausheen Ahmed, Ryan Ratts, Shine Raju, Molly Megan Gallogly, Marcos J. G. De Lima, Muhammad Rizwan Sohail · 2020 · Virology Journal
12. Innate immune detection of lipid oxidation as a threat assessment strategy
    Dania Zhivaki, Jonathan C. Kagan · 2021 · Nature reviews. Immunology
13. Fatal Lymphocytic Cardiac Damage in Coronavirus Disease 2019 (COVID-19): Autopsy Reveals a Ferroptosis Signature
    Werner Jacobs, Martin M. Y. Lammens, Annelies Kerckhofs, Evy Voets, Emily Van San, Samya Van Coillie, Cédric Peleman, Matthias Mergeay, Sabriya Sirimsi, Veerle Matheeussen et al. · 2020 · ESC Heart Failure
14. Ferroptosis in immunostimulation and immunosuppression
    Daolin Tang, Guido Kroemer, Rui Kang · 2023 · Immunological Reviews
15. Malondialdehyde epitopes as mediators of sterile inflammation
    Clara Jana‐Lui Busch, Christoph J. Binder · 2016 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
16. Pleiotropic effects of oxidized phospholipids
    Valery N. Bochkov, Bernd Gesslbauer, Christina Mauerhofer, Maria Philippova, Paul Erné, Olga Oskolkova · 2016 · Free Radical Biology and Medicine
17. Lipoprotein(a) and its role in inflammation, atherosclerosis and malignancies
    Evelyn Orsó, Gerd Schmitz · 2017 · Clinical Research in Cardiology Supplements
18. Influenza Infection Suppresses NADPH Oxidase–Dependent Phagocytic Bacterial Clearance and Enhances Susceptibility to Secondary Methicillin-Resistant Staphylococcus aureus Infection
    Keer Sun, Dennis W. Metzger · 2014 · The Journal of Immunology
19. TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection
    Laure Perrin‐Cocon, Anne Aublin‐Gex, Stefania Enza Sestito, Kari Ann Shirey, Mira C. Patel, Patrice André, Jorge C. G. Blanco, Stefanie N. Vogel, Francesco Peri, Vincent Lotteau · 2017 · Scientific Reports
20. Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets
    Masoumeh Farahani, Zahra Niknam, Leila Mohammadi Amirabad, Nasrin Amiri Dashatan, Mehdi Koushki, Mohadeseh Nemati, Fahima Danesh Pouya, Mostafa Rezaei–Tavirani, Yousef Rasmi, Lobat Tayebi · 2021 · Biomedicine & Pharmacotherapy
21. Activating Transcription Factor 3 Constitutes a Negative Feedback Mechanism That Attenuates Saturated Fatty Acid/Toll-Like Receptor 4 Signaling and Macrophage Activation in Obese Adipose Tissue
    Takayoshi Suganami, Xunmei Yuan, Yuri Shimoda, Kozue Uchio‐Yamada, Nobutaka Nakagawa, Ibuki Shirakawa, Takako Usami, Takamitsu Tsukahara, Keizo Nakayama, Yoshihiro Miyamoto et al. · 2009 · Circulation Research
22. Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola
    David S. Fedson · 2016 · Annals of Translational Medicine
23. miRNA-200c-3p is crucial in acute respiratory distress syndrome
    Qiang Liu, Jianchao Du, Xuezhong Yu, Jun Xu, Fengming Huang, Xiaoyun Li, Cong Zhang, Xiao Li, Jiahui Chang, Daozhen Shang et al. · 2017 · Cell Discovery
24. Oxidized phosphatidylcholines trigger ferroptosis in cardiomyocytes during ischemia-reperfusion injury
    Aleksandra Stamenković, Kimberley A. O’Hara, David C. Nelson, Thane G. Maddaford, Andrea L. Edel, Graham G. Maddaford, Elena Dibrov, Mohamad‐Reza Aghanoori, Lorrie A. Kirshenbaum, Paul Fernyhough et al. · 2021 · American Journal of Physiology-Heart and Circulatory Physiology
25. Recently Discovered Human Coronaviruses
    Brigitte A. Wevers, Lia van der Hoek · 2009 · Clinics in Laboratory Medicine
26. Flavonoids Activation of the Transcription Factor Nrf2 as a Hypothesis Approach for the Prevention and Modulation of SARS-CoV-2 Infection Severity
    Patricia Mendonca, Karam F. A. Soliman · 2020 · Antioxidants
27. Physiological effects of oxidized phospholipids and their cellular signaling mechanisms in inflammation
    Fiona H. Greig, Simon Kennedy, Corinne Michelle Spickett · 2011 · Free Radical Biology and Medicine
28. Trimetazidine prevents macrophage-mediated septic myocardial dysfunction via activation of the histone deacetylase sirtuin 1
    Chen, Jing, Lai, Jinsheng, Yang, Lei, Ruan, Guoran, Chaugai, Sandip, Ning, Qin, Chen, Chen, Wang, Dao Wen · 2016 · British Journal of Pharmacology
29. Natural IgM Antibodies Against Oxidation-Specific Epitopes
    Christoph J. Binder · 2010 · Journal of Clinical Immunology
30. Emodin Inhibition of Influenza A Virus Replication and Influenza Viral Pneumonia via the Nrf2, TLR4, p38/JNK and NF-kappaB Pathways
    Jianping Dai, Qianwen Wang, Yun Su, Liming Gu, Ying Zhao, Xiao-Xua Chen, Cheng Chen, Weizhong Li, Gefei Wang, Kangsheng Li · 2017 · Molecules
31. The role of toll-like receptors in acute and chronic lung inflammation
    Erin I. Lafferty, Salman T. Qureshi, Markus Schnare · 2010 · Journal of Inflammation
32. Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory Drugs
    Irene Ramos, Ana Fernández-Sesma · 2015 · Frontiers in Immunology
33. Free radical oxidation of cardiolipin: chemical mechanisms, detection and implication in apoptosis, mitochondrial dysfunction and human diseases
    Huiyong Yin, Mingjiang Zhu · 2012 · Free Radical Research
34. Mitochondrial reactive oxygen species enable proinflammatory signaling through disulfide linkage of NEMO
    Herb, Marc, Gluschko, Alexander, Wiegmann, Katja, Farid, Alina, Wolf, Anne, Utermöhlen, Olaf, Krut, Oleg, Krönke, Martin, Schramm, Michael · 2019 · Science Signaling
35. TLR4-Targeting Therapeutics: Structural Basis and Computer-Aided Drug Discovery Approaches
    Qurat Ul Ain, Maria Batool, Sangdun Choi · 2020 · Molecules
36. Potent lipoprotein(a) lowering following apolipoprotein(a) antisense treatment reduces the pro-inflammatory activation of circulating monocytes in patients with elevated lipoprotein(a)
    Lotte C.A. Stiekema, Koen H.M. Prange, Renate M. Hoogeveen, Simone L. Verweij, Jeffrey Kroon, Johan G. Schnitzler, Kim E. Dzobo, Arjen J. Cupido, Sotirios Tsimikas, Erik S.G. Stroes et al. · 2020 · European Heart Journal
37. Toll-Like Receptors and COVID-19: A Two-Faced Story with an Exciting Ending
    Livia Onofrio, Michele Caraglia, Gaetano Facchini, Vincenzo Margherita, Sabino De Placido, Carlo Buonerba · 2020 · Future Science OA
38. Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies
    Dimitrios Tsiantoulas, Thomas Perkmann, Taras Afonyushkin, Andreas Mangold, Thomas A Prohaska, Nikolina Papac-Miličević, Vincent Millischer, Caroline Bartel, Sohvi Hörkkö, Chantal M. Boulanger et al. · 2014 · Journal of Lipid Research
39. Oxidized Phospholipids Are More Potent Antagonists of Lipopolysaccharide than Inducers of Inflammation
    Olga Oskolkova, Taras Afonyushkin, Beatrix Preinerstorfer, Wolfgang Bicker, Elena von Schlieffen, Eva Hainzl, Svitlana Demyanets, Gernot Schabbauer, Wolfgang F. Lindner, Alexandros D. Tselepis et al. · 2010 · The Journal of Immunology
40. NETosis and NADPH oxidase: at the intersection of host defense, inflammation, and injury
    Nikolaos G. Almyroudis, Melissa J. Grimm, Bruce A. Davidson, Marc Röhm, Constantin Felix Urban, Brahm H. Segal · 2013 · Frontiers in Immunology
41. Global Trends in Research of Macrophages Associated With Acute Lung Injury Over Past 10 Years: A Bibliometric Analysis
    Sheng Wang, Huanping Zhou, Zheng Li, Wanli Zhu, Lina Zhu, Di Feng, Juan Wei, Guannan Chen, Xiaohong Jin, Hao Yang et al. · 2021 · Frontiers in Immunology
42. Role of the Innate Cytokine Storm Induced by the Influenza A Virus
    Yinuo Gu, Alan Hsu, Zhiqiang Pang, He Pan, Xu Zuo, Guoqiang Wang, Jingtong Zheng, Fang Wang · 2019 · Viral Immunology
43. Angiotensin-converting enzyme 2 attenuates inflammatory response and oxidative stress in hyperoxic lung injury by regulating NF-κB and Nrf2 pathways
    Yuying Fang, F Gao, Zi-hao Liu · 2019 · QJM
44. Ebselen and Congeners Inhibit NADPH Oxidase 2-Dependent Superoxide Generation by Interrupting the Binding of Regulatory Subunits
    Susan M.E. Smith, Jaeki Min, Thota Ganesh, Becky A. Diebold, Tsukasa Kawahara, Yerun Zhu, James W. McCoy, Aiming Sun, James P. Snyder, Haian Fu et al. · 2012 · Chemistry & Biology
45. Ulinastatin Protects Against LPS-Induced Acute Lung Injury By Attenuating TLR4/NF-κB Pathway Activation and Reducing Inflammatory Mediators
    Chao Cao, Chengfen Yin, Songtao Shou, Jun Wang, Lechang Yu, Xuening Li, Yanfen Chai · 2018 · Shock
46. Particulate matter air pollutants and cardiovascular disease: Strategies for intervention
    Ankit Aryal, Ashlyn C. Harmon, Tammy R. Dugas · 2021 · Pharmacology & Therapeutics
47. Platelets in the pathogenesis of acute respiratory distress syndrome
    Hemang Yadav, Daryl Jon Kor · 2015 · American Journal of Physiology-Lung Cellular and Molecular Physiology
48. Toll-like receptors 2 and 4: initiators of non-septic inflammation in critical care medicine?
    Emmanuel Lorne, Hervé Dupont, Edward H Abraham · 2010 · Intensive Care Medicine
49. Neutrophils in viral infection
    Victor Naumenko, Madison Turk, Craig N. Jenne, Seok‐Joo Kim · 2018 · Cell and Tissue Research
50. Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID‐19
    Adeleh Sahebnasagh, Fatemeh Saghafi, Mohammadreza Safdari, Masoud Khataminia, Afsaneh Sadremomtaz, Zeinab Talaei, Hassan Rezai Ghaleno, Mahdi Bagheri, Solomon Habtemariam, Razieh Avan · 2020 · Journal of Clinical Pharmacy and Therapeutics
51. Toll-like Receptor 4 Signaling by Follicular Dendritic Cells Is Pivotal for Germinal Center Onset and Affinity Maturation
    Alexandre Garin, Michael Meyer‐Hermann, Mathias Contie, Marc Thilo Figge, Vanessa Buatois, Matthias Gunzer, Kai‐Michael Toellner, Greg Elson, Marie H. Kosco‐Vilbois · 2010 · Immunity
52. Akt-Mediated Transactivation of the S1P 1 Receptor in Caveolin-Enriched Microdomains Regulates Endothelial Barrier Enhancement by Oxidized Phospholipids
    Patrick A. Singleton, Santipongse Chatchavalvanich, Panfeng Fu, Junjie Xing, Anna A. Birukova, Jennifer A. Fortune, Alexander M. Klibanov, Joe G. N. Garcia, Konstantin G. Birukov · 2009 · Circulation Research
53. TLRs in pulmonary diseases
    Shweta Arora, Shaniya Ahmad, Rasha Irshad, Yamini Goyal, Sahar Rafat, Neha Siddiqui, Kapil Dev, Mohammad Husain, Shakir Ali, Anant Mohan et al. · 2019 · Life Sciences
54. Augmented Lung Inflammation Protects against Influenza A Pneumonia
    Michael J. Tuvim, Scott E. Evans, Cecilia G. Clement, Burton F. Dickey, Brian E. Gilbert · 2009 · PLoS ONE
55. Malondialdehyde Epitopes as Targets of Immunity and the Implications for Atherosclerosis
    Nikolina Papac-Miličević, Clara Jana‐Lui Busch, Christoph J. Binder · 2016 · Advances in immunology
56. Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions
    Robert Scott Root-Bernstein · 2021 · International Journal of Molecular Sciences
57. NADPH Oxidases in Lung Health and Disease
    Karen F. Bernard, Louise Hecker, Tracy Luckhardt, Guangjie Cheng, Victor John Thannickal · 2013 · Antioxidants and Redox Signaling
58. Changes in H5N1 influenza virus hemagglutinin receptor binding domain affect systemic spread
    Hui‐Ling Yen, Jerry R. Aldridge, Adrianus C. M. Boon, Natalia A. Ilyushina, Rachelle Salomon, Diane J. Hulse-Post, Henju Marjuki, John Franks, David A. Boltz, Dorothy A. Bush et al. · 2008 · Proceedings of the National Academy of Sciences
59. Statins May Decrease the Fatality Rate of Middle East Respiratory Syndrome Infection
    Shu Yuan · 2015 · mBio
60. Respiratory viral sepsis: epidemiology, pathophysiology, diagnosis and treatment
    Xiaoying Gu, Fei Zhou, Yeming Wang, Guohui Fan, Bin Cao · 2020 · European Respiratory Review
61. Andrographolide inhibits influenza A virus-induced inflammation in a murine model through NF-κB and JAK-STAT signaling pathway
    Yi Ding, Lizhu Chen, Wenjiao Wu, Jie Wu Yang, Zifeng Yang, Shuwen Liu · 2017 · Microbes and Infection
62. Enzymatically oxidized phospholipids assume center stage as essential regulators of innate immunity and cell death
    Valerie B. O’Donnell, Maceler Aldrovandi, Robert C. Murphy, Gerhard Krönke · 2019 · Science Signaling
63. Type I interferon limits influenza virus-induced acute lung injury by regulation of excessive inflammation in mice
    Yojiro Arimori, Risa Nakamura, Hisakata Yamada, Kensuke Shibata, Naoyoshi Maeda, Tetsuo Kase, Yasunobu Yoshikai · 2013 · Antiviral Research
64. Apigenin C-glycosides of Microcos paniculata protects lipopolysaccharide induced apoptosis and inflammation in acute lung injury through TLR4 signaling pathway
    Kunping Li, Zhuoru He, Xin-Qiu-Yue Wang, Miguel A. Pineda, Runbao Chen, Haiqi Liu, Kai-Ting Ma, Huan‐Jia Shen, Chunhui Wu, Ningtin Huang et al. · 2018 · Free Radical Biology and Medicine
65. Mechanisms of Toll-Like Receptor 4 (TLR4)-Mediated Inflammation After Cold Ischemia/Reperfusion in the Heart
    David J. Kaczorowski, Atsunori Nakao, Raghuveer Vallabhaneni, Kevin Patrick Mollen, Ryujiro Sugimoto, Junichi Kohmoto, Brian Scott Zuckerbraun, Kenneth R. McCurry, Timothy R. Billiar · 2009 · Transplantation
66. Postinfluenza bacterial pneumonia: Host defenses gone awry
    Ballinger, Megan N., Standiford, Theodore J. · 2010 · Journal of Interferon & Cytokine Research
67. RETRACTED ARTICLE: Angiotensin-converting enzyme 2/angiotensin-(1–7)/Mas axis prevents lipopolysaccharide–induced apoptosis of pulmonary microvascular endothelial cells by inhibiting JNK/NF–κB pathways
    Yingchuan Li, Yongmei Cao, Zhen Zeng, Mengfan Liang, Ying Xue, Caihua Xi, Ming Sheng Zhou, Wei Jiang · 2015 · Scientific Reports · Retracted
68. Eriodictyol, a plant flavonoid, attenuates LPS-induced acute lung injury through its antioxidative and anti-inflammatory activity
    Guangfa Zhu, Hongjuan Guo, Yan Xin Huang, Chunting Wu, XIANG-FENG ZHANG · 2015 · Experimental and Therapeutic Medicine
69. Inducible Nitric Oxide Contributes to Viral Pathogenesis Following Highly Pathogenic Influenza Virus Infection in Mice
    Lucy A. Perrone, Jessica A. Belser, Debra A. Wadford, Jacqueline M. Katz, Terrence M. Tumpey · 2013 · The Journal of Infectious Diseases
70. Lipids, inflammasomes, metabolism, and disease
    Paras Anand · 2020 · Immunological Reviews
71. Innate Immune Sensing of Influenza A Virus
    Gaurav Malik, Yan Zhou · 2020 · Viruses
72. Potential of natural astaxanthin in alleviating the risk of cytokine storm in COVID-19
    Jayanta Talukdar, Bhaskar Bhadra, Tomal Dattaroy, Vinod L. Nagle, Santanu Dasgupta · 2020 · Biomedicine & Pharmacotherapy
73. [WITHDRAWN] Retinal Vasculature in Development and Diseases
    Ye Sun, Lois E. H. Smith · 2018 · Annual Review of Vision Science · Retracted
74. Age-induced NLRP3 Inflammasome Over-activation Increases Lethality of SARS-CoV-2 Pneumonia in Elderly Patients
    Pedro C. Lara, David Macías-Verde, Javier Burgos-Burgos · 2020 · Aging and Disease
75. CXCL10 Chemokine: A Critical Player in RNA and DNA Viral Infections
    Noha Mousaad Elemam, Iman Mamdouh Talaat, Azzam A. Maghazachi · 2022 · Viruses
76. Toll-like receptor 4 senses oxidative stress mediated by the oxidation of phospholipids in extracellular vesicles
    Mateja Manček‐Keber, Mojca Frank‐Bertoncelj, Iva Hafner‐Bratkovič, Anže Smole, Mateja Starbek Zorko, Nina Pirher, Silvia Hayer, Veronika Kralj‐Iglič, Blaž Rozman, Nejc Ilc et al. · 2015 · Science Signaling
77. Novel Drugs Targeting Toll-Like Receptors for Antiviral Therapy
    Mira C. Patel, Kari Ann Shirey, Lioubov M. Pletneva, Marina S. Boukhvalova, Alfredo Garzino Demo, Stefanie N. Vogel, Jorge C. G. Blanco · 2014 · Future Virology
78. Metabolomics Investigation Reveals Metabolite Mediators Associated with Acute Lung Injury and Repair in a Murine Model of Influenza Pneumonia
    Cui Liang, Dahai Zheng, Yie Hou Lee, Tze Khee Chan, Yadunanda Kumar, Wanxing Eugene Ho, Jian Zhu Chen, Steven R. Tannenbaum, Choon Nam Ong · 2016 · Scientific Reports
79. Significance of NETs Formation in COVID-19
    Karolina Janiuk, Ewa Jabłońska, Marzena Garley · 2021 · Cells
80. B7H3 ameliorates LPS-induced acute lung injury via attenuation of neutrophil migration and infiltration
    Yan Li, Jie Huang, Niamh M. Foley, Yunyun Xu, Yi Ping Li, Jian Pan, H. Paul Redmond, Jiang Huai Wang, Jian Wang · 2016 · Scientific Reports
81. Trauma hemorrhagic shock-induced lung injury involves a gut-lymph-induced TLR4 pathway in mice
    Reino, Diego C., Pisarenko, Vadim, Palange, David, Doucet, Danielle, Bonitz, Robert P., Lu, Qi, Colorado, Iriana, Sheth, Sharvil U., Chandler, Benjamin, Kannan, Kolenkode B. et al. · 2011 · PLoS ONE
82. The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?
    Gerwyn Morris, Chiara C. Bortolasci, Basant K. Puri, Wolfgang Marx, Adrienne E O'Neil, Eugene Athan, Ken R. Walder, Michael Berk, LISA S. OLIVE, Andre Ferrer Carvalho et al. · 2021 · Cytokine
83. Compartmentalized regulation of lipid signaling in oxidative stress and inflammation: Plasmalogens, oxidized lipids and ferroptosis as new paradigms of bioactive lipid research
    Alma M. Astudillo, María A. Balboa, Jesús Balsinde · 2022 · Progress in Lipid Research
84. Interferons in health and disease
    Daniel F. R. Boehmer, Ivan Zanoni · 2025 · Cell
85. Innate immunity as the trigger of systemic autoimmune diseases
    Victoria Saferding, Stephan Blüml · 2019 · Journal of Autoimmunity
86. NOX2 As a Target for Drug Development: Indications, Possible Complications, and Progress
    Becky A. Diebold, Susan M. Smith, Li Yang, J. David Lambeth · 2014 · Antioxidants and Redox Signaling
87. Reactive oxygen species activate NFκB (p65) and p53 and induce apoptosis in RVFV infected liver cells
    Aarthi Narayanan, Moushimi Amaya, Kelsey Voss, Myung Chung, Ashwini Benedict, Gavin C. Sampey, Kylene Kehn‐Hall, Alessandra Luchini, Lance A. Liotta, Charles Bailey et al. · 2013 · Virology
88. Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options
    Yasaman Nazerian, Mobina Ghasemi, Younes Yassaghi, Amirhossein Nazerian, Seyed Mahmoud Hashemi · 2022 · International Immunopharmacology
89. Toll/Interleukin-1 Receptor Domain-Containing Adapter Inducing Interferon-β Mediates Microglial Phagocytosis of Degenerating Axons
    Suneil Hosmane, Million Adane Tegenge, Labchan Rajbhandari, Prech Uapinyoying, Nishant Ganesh Kumar, Nitish V. Thakor, Arun Venkatesan · 2012 · Journal of Neuroscience
90. Inhibition of Mammalian Target of Rapamycin Augments Lipopolysaccharide-Induced Lung Injury and Apoptosis
    Jill A. Fielhaber, Scott F. Carroll, Anders Bondo Dydensborg, Mitra Shourian, Alexandra Triantafillopoulos, Sharon Harel, Sabah N. A. Hussain, Maxime Bouchard, Salman T. Qureshi, Arnold S. Kristof · 2012 · The Journal of Immunology
91. The role of oxidative stress in the pathogenesis of infections with coronaviruses
    Chandrima Gain, Sihyeong Song, Tyler Angtuaco, Sandro Satta, Theodoros Kelesidis · 2023 · Frontiers in Microbiology
92. Dynamics of pulmonary endothelial barrier function in acute inflammation: mechanisms and therapeutic perspectives
    Holger Müller-Redetzky, Norbert Suttorp, Martin Witzenrath · 2014 · Cell and Tissue Research
93. Innate Immune Responses to Avian Influenza Viruses in Ducks and Chickens
    Danyel Evseev, Katharine E. Magor · 2019 · Veterinary Sciences
94. Reactive oxygen species regulation by NCF1 governs ferroptosis susceptibility of Kupffer cells to MASH
    Jing Zhang, Yu Wang, Meiyang Fan, Yanglong Guan, Wentao Zhang, Fumeng Huang, Zhengqiang Zhang, Xiaomeng Li, Bingyu Yuan, Wenbin Liu et al. · 2024 · Cell Metabolism
95. Confronting the next influenza pandemic with anti‐inflammatory and immunomodulatory agents: why they are needed and how they might work
    David S. Fedson · 2009 · Influenza and Other Respiratory Viruses
96. Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?
    Simone Cristina Soares Brandão, Júlia de Oliveira Xavier Ramos, Luca Terracini Dompieri, Emmanuelle Tenório Albuquerque Madruga Godoi, José Luiz de Figueiredo, EMANUEL SÁVIO CAVALCANTI SARINHO, Sarvesh Chelvanambi, Masanori Aikawa · 2020 · Cytokine & Growth Factor Reviews
97. Principles of Source Control in the Management of Sepsis
    John C. Marshall, Abdullah al Naqbi · 2009 · Critical Care Clinics
98. Multi-Hit Inhibition of Circulating and Cell-Associated Components of the Toll-Like Receptor 4 Pathway by Oxidized Phospholipids
    Elena von Schlieffen, Olga Oskolkova, Gernot Schabbauer, Флориан Грубер, Stephan Blüml, Melinda Genest, Alexandra Kadl, Claudia L. Marsik, Sylvia Knapp, Jesse C. Chow et al. · 2008 · Arteriosclerosis Thrombosis and Vascular Biology
99. Reduction of myocardial ischaemia–reperfusion injury by inactivating oxidized phospholipids
    Calvin Yeang, Devin Hasanally, Xuchu Que, Ming‐Yow Hung, Aleksandra Stamenković, David Chan, Rakesh Chaudhary, Victoria Margulets, Andrea L. Edel, Masahiko Hoshijima et al. · 2018 · Cardiovascular Research
100. Mitochondrial reactive oxygen species contribute to pathological inflammation during influenza a virus infection in mice
     To, Eunice E., Erlich, Jonathan R., Liong, Felicia, Luong, Raymond, Liong, Stella, Esaq, Farisha, Oseghale, Osezua, Anthony, Desiree, McQualter, Jonathan, Bozinovski, Steven et al. · 2020 · Antioxidants & Redox Signaling